CTLA4 and neoplasm: Additionally, there were significant differences in immunoexpression intensity of CTLA-4 in TCs of the various tumor subtypes (p < 0.0001); specifically, it was more intense in YST, CH and TE, when compared to EC or SE (Figure 5B).